Your browser doesn't support javascript.
loading
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
Tosco, Lorenzo; Laenen, Annouschka; Gevaert, Thomas; Salmon, Isabelle; Decaestecker, Christine; Davicioni, Elai; Buerki, Christine; Claessens, Frank; Swinnen, Johan; Goffin, Karolien; Oyen, Raymond; Everaerts, Wouter; Moris, Lisa; De Meerleer, Gert; Haustermans, Karin; Joniau, Steven.
Afiliação
  • Tosco L; Urology, Department of Development and Regeneration, University Hospitals Leuven, Leuven, Belgium.
  • Laenen A; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Gevaert T; Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Belgium.
  • Salmon I; Laboratory of Experimental Urology, Organ Systems, KU Leuven, Leuven, Belgium.
  • Decaestecker C; Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Davicioni E; Department of Pathology, AZ Klina, Brasschaat, Belgium.
  • Buerki C; DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
  • Claessens F; Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Swinnen J; DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Gosselies, Belgium.
  • Goffin K; Laboratories of Image, Signal processing & Acoustics, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Oyen R; GenomeDX, Biosciences Inc, Vancouver, BC, Canada.
  • Everaerts W; GenomeDX, Biosciences Inc, Vancouver, BC, Canada.
  • Moris L; KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Molecular Endocrinology, Leuven, Belgium.
  • De Meerleer G; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Haustermans K; Leuven Cancer Institute, KU Leuven, University of Leuven, Leuven, Belgium.
  • Joniau S; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
BMC Cancer ; 18(1): 354, 2018 04 02.
Article em En | MEDLINE | ID: mdl-29606109
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Prostatectomia / Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Protocolos Clínicos Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Prostatectomia / Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Protocolos Clínicos Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica